Patients with severe asthma who are typically underrepresented in clinical studies experienced improved outcomes with ...
Nebulized treprostinil (Tyvaso) reduced lung function decline from idiopathic pulmonary fibrosis (IPF) in the pivotal TETON-1 ...
Two phase 3, randomized trials of inhaled treprostinil for idiopathic pulmonary fibrosis (IPF) were conducted on the basis of preclinical and clinical evidence of an antifibrotic mechanism.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results